Bright Minds Biosciences is rated Hold due to heavy dilution, overvaluation, and reliance on a single late-stage asset, BMB-101. BMB-101 targets drug-resistant epilepsies with strong Phase 2 results ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results